Datavault AI Soars: Revenue Forecast Jumps 33%, Projects 1,300% Growth
February 18, 2026 — Datavault AI (DVLT) raises its 2025 revenue forecast to $38-40M, marking 1,300% growth, and reaffirms a $200M target for 2026, driven by AI data monetization.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
February 18, 2026 — Datavault AI (DVLT) raises its 2025 revenue forecast to $38-40M, marking 1,300% growth, and reaffirms a $200M target for 2026, driven by AI data monetization.
February 18, 2026 — LIXTE Biotechnology appoints Sidney Braun as CEO of Liora Technologies Europe to advance proton therapy platform. Learn about their cancer treatment innovations.
February 18, 2026 — Sportradar completes IMG Arena integration, adding 30,000 streams and rights to tennis Grand Slams, MLS, and more. Enhances sports tech with innovation and iGaming focus.
February 18, 2026 — Med Holdings Group negotiates with urology expert Dr. Harvey Samowitz while expanding to Florida and launching TotallBody.com digital platform. Stock up 500%.
February 18, 2026 — LaFleur Minerals reports progress restarting Beacon Gold Mill in Québec, advancing mine-to-mill strategy with Swanson Gold Project in Abitibi Greenstone Belt.
February 18, 2026 — Olenox Industries appoints Erik Blum & Adam Falkoff to its board, strengthening finance & strategy as it completes its shift to a vertically integrated energy company.
February 18, 2026 — SEGG Media appoints Veloce CEO Daniel Bailey to its board following acquisition, boosting expertise in digital monetization & brand partnerships for its 2026 growth strategy in sports & gaming.
February 18, 2026 — Wearable Devices Ltd. gains recognition in AINewsWire editorial for bridging human intent with AI execution through neural input technology and ai6 Labs ecosystem.
February 18, 2026 — Earth Science Tech (ETST) reports Q3 revenue of $8.4M, up 14.1%, with net income surging 341% to $910K. The company boasts a 76.3% gross margin and no debt.
February 18, 2026 — LIXTE Biotechnology appoints Sidney Braun as CEO of Liora Technologies Europe to advance proton therapy platform while progressing cancer drug LB-100 through clinical trials.
February 18, 2026 — LIXTE Biotechnology combines LB-100 tumor-sensitizing compound with Liora's LiGHT proton therapy system in dual strategy to overcome cancer treatment barriers and improve patient outcomes.
February 18, 2026 — Lahontan Gold announces new drill results from West Santa Fe in Nevada, confirming significant near-surface gold-silver mineralization open for expansion, with potential for open-pit mining.
February 18, 2026 — Nevada Organic Phosphate Inc. announces 2026 drill program at Murdock Mountain, expanding its unique North American phosphate project with regulatory oversight.
February 18, 2026 — Ares Strategic Mining begins fluorspar ore stockpiling at Utah's Lost Sheep Mine, marking production transition for this U.S. critical mineral essential for manufacturing and clean energy.
February 18, 2026 — ParaZero Technologies achieves first net-based interception of 70 mph drone with DefendAir system. Aerospace defense breakthrough enhances counter-drone capabilities for military and security applications.
February 18, 2026 — Oncotelic Therapeutics featured in BioMedWire editorial on biotech M&A trends focusing on late-stage oncology & CNS assets. Learn about its OT-101 platform & strategic position.
February 18, 2026 — Platinum prices surge past $2,000/oz with 127% gains, but major miners remain cautious about new investments. Industry prefers payouts over capital expenditure despite record prices.
February 18, 2026 — Wheaton Precious Metals exceeds 2025 production guidance with 692,000 GEOs and projects 50% growth to 1.2 million GEOs by 2030. Learn about their streaming model and expansion plans.
February 18, 2026 — SPARC AI launches a GPS-denied navigation & laser-free target acquisition app on a defense smartphone, while planning a U.S. subsidiary for defense market expansion.
February 18, 2026 — GeoVax Labs licenses Emory University technology to combine Gedeptin with immune checkpoint inhibitors for enhanced solid tumor treatment. Strengthens cancer immunotherapy portfolio.